Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
Top Cited Papers
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 357 (9272), 1905-1914
- https://doi.org/10.1016/s0140-6736(00)05059-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Statistical Methods for Comparison to Placebo in Active-Control TrialsDrug Information Journal, 2001
- Treatment of Reinfarction After Thrombolytic Therapy for Acute Myocardial InfarctionCirculation, 2001
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- A Comparison of Reteplase with Alteplase for Acute Myocardial InfarctionNew England Journal of Medicine, 1997
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial)The American Journal of Cardiology, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?Circulation, 1993
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983